Uses of antiseizure medication among pregnant women with epilepsy and risk of adverse obstetric outcomes: A group‐based trajectory analysis
Epilepsia · 2024
DOI: 10.1111/epi.18064 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Yi-Chin Lin und 7 weiteren Autor:innen. Beteiligte Einrichtung: Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan. Hauptthemen laut MEDLINE: Anticonvulsants, Epilepsy, Pregnancy Complications, Premature Birth. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Science and Technology Council.
Abstract (Originalsprache)
Objective
This study was undertaken to examine the association between different patterns of antiseizure medication (ASM) use during pregnancy and adverse obstetric outcomes (preterm birth, low birth weight [LBW], and small for gestational age [SGA]).
Methods
This retrospective cohort study used the Birth Certificate Application and National Health Insurance data in Taiwan (January 1, 2004 through December 31, 2018). We retrieved weekly ASM among pregnant women with epilepsy who were prepregnancy chronic users and used group‐based trajectory modeling to identify distinct patterns of use. Logistic regressions were adopted to examine the association between patterns of ASM use and risk of preterm birth, LBW, and SGA. In addition, we revealed postnatal ASM utilization pattern among these prepregnancy chronic users as an exploratory study.
Results
Of 2175 pregnant women with epilepsy, we identified four patterns of ASM use during pregnancy: frequent and continuous (64.87%), frequent but discontinuous (7.08%), intermittent (19.72%), and intermittent and discontinuous users (8.32%). Compared to frequent and continuous users, the adjusted odds ratios for preterm birth in frequent but discontinuous, intermittent, and intermittent and discontinuous users were .83 (95% confidence interval [CI] = .47–1.48), .71 (95% CI = .47–1.05), and .88 (95% CI = .52–1.49), respectively. Similar results were observed for LBW and SGA. In the exploratory study, we found that most of our study subjects maintained the same patterns before and after delivery. Significance After considering duration and timing of exposure, our study did not find an association between four distinct patterns of ASM use and adverse obstetric outcomes among women with epilepsy. The findings suggested that optimal seizure control could be received for pregnant women with epilepsy after evaluating the risks and benefits.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Graduate Institute of Clinical Pharmacy, College of Medicine, National Taiwan University, Taipei, Taiwan.
- Department of Pharmacy, Shuang Ho Hospital, Taipei Medical University, New Taipei City, Taiwan.
- Taiwan Drug Relief Foundation, Taipei, Taiwan.
- Center for Healthy Longevity and Aging Sciences, National Yang Ming Chiao Tung University, Taipei, Taiwan.
- Department of Obstetrics and Gynecology, MacKay Memorial Hospital, Taipei, Taiwan.
- Neurological Institute, Taipei Veterans General Hospital, Taipei, Taiwan.
ORCID-Profile: Fei-Yuan Hsiao
Förderung
- National Science and Technology Council
Zitieren
APA
Lin, Y. C., Lin, C. W., Meng, L. C., Huang, S. T., Chen, Y. Y., Wang, S. J., Chan, K. A., & Hsiao, F. Y. (2024). Uses of antiseizure medication among pregnant women with epilepsy and risk of adverse obstetric outcomes: A group‐based trajectory analysis. Epilepsia. https://doi.org/10.1111/epi.18064
Vancouver
Lin YC, Lin CW, Meng LC, Huang ST, Chen YY, Wang SJ, et al. Uses of antiseizure medication among pregnant women with epilepsy and risk of adverse obstetric outcomes: A group‐based trajectory analysis. Epilepsia. 2024. doi:10.1111/epi.18064
BibTeX
@article{Lin2024,
author = {Lin, Yi-Chin and Lin, Chih-Wan and Meng, Lin-Chieh and Huang, Shih-Tsung and Chen, Yi-Yung and Wang, Shuu-Jiun and Chan, K Arnold and Hsiao, Fei-Yuan},
title = {Uses of antiseizure medication among pregnant women with epilepsy and risk of adverse obstetric outcomes: A group‐based trajectory analysis},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.18064}
}
EUVIMED